P347 Prenatal exposure to mercury and the size of a newborn's cerebellum

Prpić, Igor; Milardović, Ana; Bilić, Iva; Krajina, Robert; Petrović, Oleg; Špirić, Zdravko; Horvat, Milena; Tratnik, Janja Snoj; Mazej, Darja

doi:10.1016/s1090-3798(09)70405-2

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There were 45 retrospective 3,[5][6][7][8][9][10][13][14][15]19,20,[22][23][24][25] and 21 prospective 11, [16][17][18]21,26,[60][61][62][63][64][65][66][67][68][69][70][71][72][73][74] cohort studies, 9 case-control studies, 4,12,75-81 and 1 cross-sectional study. 82 Sixty-two articles had a low risk of bias 3-11, 13-16, 18-26, 31-40, 42, 45, 46, 48, 50-60, 62-71,74-77,79 and 14 a high risk of bias 12,17,41,43,44,47,49,61,72,73,78,[80][81][82] (eTable 2 in Supplement 1).…”

Section: Resultsmentioning

confidence: 99%

Comparison of Perinatal Outcomes for Women With and Without Epilepsy

et al. 2023

View full text Add to dashboard Cite

ImportancePregnant women who have epilepsy need adequate engagement, information, and pregnancy planning and management to improve pregnancy outcomes.ObjectiveTo investigate perinatal outcomes in women with epilepsy compared with women without epilepsy.Data SourcesOvid MEDLINE, Embase, CINAHL, and PsycINFO were searched with no language or date restrictions (database inception through December 6, 2022). Searches also included OpenGrey and Google Scholar and manual searching in journals and reference lists of included studies.Study SelectionAll observational studies comparing women with and without epilepsy were included.Data Extraction and SynthesisThe PRISMA checklist was used for abstracting data and the Newcastle-Ottawa Scale for risk-of-bias assessment. Data extraction and risk-of-bias assessment were done independently by 2 authors with mediation conducted independently by a third author. Pooled unadjusted odds ratios (OR) or mean differences were reported with 95% CI from random-effects (I2 heterogeneity statistic &gt;50%) or fixed-effects (I2 &lt; 50%) meta-analyses.Main Outcomes and MeasuresMaternal, fetal, and neonatal complications.ResultsOf 8313 articles identified, 76 were included in the meta-analyses. Women with epilepsy had increased odds of miscarriage (12 articles, 25 478 pregnancies; OR, 1.62; 95% CI, 1.15-2.29), stillbirth (20 articles, 28 134 229 pregnancies; OR, 1.37; 95% CI, 1.29-1.47), preterm birth (37 articles, 29 268 866 pregnancies; OR, 1.41; 95% CI, 1.32-1.51) and maternal death (4 articles, 23 288 083 pregnancies; OR, 5.00; 95% CI, 1.38-18.04). Neonates born to women with epilepsy had increased odds of congenital conditions (29 articles, 24 238 334 pregnancies; OR, 1.88; 95% CI, 1.66-2.12), neonatal intensive care unit admission (8 articles, 1 204 428 pregnancies; OR, 1.99; 95% CI, 1.58-2.51), and neonatal or infant death (13 articles, 1 426 692 pregnancies; OR, 1.87; 95% CI, 1.56-2.24). The increased odds of poor outcomes was increased with greater use of antiseizure medication.Conclusions and RelevanceThis systematic review and meta-analysis found that women with epilepsy have worse perinatal outcomes compared with women without epilepsy. Women with epilepsy should receive pregnancy counseling from an epilepsy specialist who can also optimize their antiseizure medication regimen before and during pregnancy.

show abstract